Scinovex
article Open Access

Clinical presentation and treatment outcome of non-surgical endodontic intervention for extraoral cutaneous fistula of chronic periapical lesions in Kashmiri population: A randomised clinical trial

International Journal of Applied Dental Sciences · 2019 · Vol. 5(2) · pp. 392–396

Abstract

Background: To present a study investigating the clinical characteristics, morphology, diagnosis and treatment of an Extraoral cutaneous fistulas of odontogenic origin. Methods: This study was performed at Govt. Dental College & Hospital, Srinagar from Jan 2016 to Dec 2017. Following clinical and radiographic examinations, the paths and origins of sinus fistulas were determined. Investigated factors were gender, age, morphology, location, originating tooth, time to evolution, recurrence, and treatment method. Results: Fifteen patients were examined & fifteen fistulas were diagnosed as odontogenic cutaneous fistulas. The most common morphology was dimpling (n=7, 46%). The most common site was the mandibular body. The majority of patients had experienced recurrence after treatment in previous clinics that had failed to diagnose odontogenic cutaneous fistula. Non-Surgical Endodontic treatment was performed in all cases. None showed signs of recurrence. Conclusion: Extraoral and dental examinations are required to make a diagnosis of odontogenic cutaneous fistula. Thus, cooperation between dermatologists and dentists is essential.

Endodontics and Root Canal TreatmentsOral and Maxillofacial PathologyDental Radiography and ImagingMedicineOdontogenicFistulaDentistryPresentation (obstetrics)DermatologySurgeryPathology
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
27%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Clinical presentation and treatment outcome of non-surgical endodontic intervention for extraoral cutaneous fistula of chronic periapical lesions in Kashmiri population: A randomised clinical trial · Scinovex